Literature DB >> 17322378

Cathepsin g is required for sustained inflammation and tissue injury after reperfusion of ischemic kidneys.

Naohiko Shimoda1, Nobuyuki Fukazawa, Katsuya Nonomura, Robert L Fairchild.   

Abstract

Neutrophil activation to release granules containing proteases and other enzymes is a primary cause of tissue damage during ischemia/reperfusion injury. Because the contribution of specific granule enzymes to this injury remains poorly defined, the role of cathepsin G in renal ischemia/reperfusion injury was tested. Bilateral renal ischemia led to the expiration of 64% of wild-type mice within 4 days of reperfusion, whereas all cathepsin G-deficient mice survived. Serum creatinine increased to similar levels at 24 hours after reperfusion and then decreased to background in both groups of mice. Ischemic kidneys from both groups had similar levels of neutrophil infiltration and of CXCL1, CXCL2, and myeloperoxidase protein 9 hours after reperfusion, but at 24 hours, these acute inflammatory response components were decreased more than 50% in kidneys from cathepsin G-deficient versus wild-type mice. Ischemic kidneys from surviving wild-type mice had severe tubular necrosis and tubular cell apoptosis 24 hours after reperfusion with subsequent development of fibrosis 30 days later. In contrast, ischemic kidneys from cathepsin G-deficient mice had a 70% decrease in tubular cell apoptosis with little detectable collagen deposition. These data identify cathepsin G as a critical component sustaining neutrophil-mediated acute tissue pathology and subsequent fibrosis after renal ischemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17322378      PMCID: PMC1864870          DOI: 10.2353/ajpath.2007.060486

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

Review 1.  The neutrophil as a cellular source of chemokines.

Authors:  P Scapini; J A Lapinet-Vera; S Gasperini; F Calzetti; F Bazzoni; M A Cassatella
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

Review 2.  More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control.

Authors:  U Bank; S Ansorge
Journal:  J Leukoc Biol       Date:  2001-02       Impact factor: 4.962

3.  Prolonged ischemia enhances acute rejection in rat kidney grafts.

Authors:  E A Kouwenhoven; R W de Bruin; I M Bajema; R L Marquet; J N IJzermans
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

4.  Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G.

Authors:  J Tkalcevic; M Novelli; M Phylactides; J P Iredale; A W Segal; J Roes
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

5.  Normal neutrophil function in cathepsin G-deficient mice.

Authors:  D M MacIvor; S D Shapiro; C T Pham; A Belaaouaj; S N Abraham; T J Ley
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

Review 6.  Molecular and cellular events associated with ischemia/reperfusion injury.

Authors:  I Laskowski; J Pratschke; M J Wilhelm; M Gasser; N L Tilney
Journal:  Ann Transplant       Date:  2000       Impact factor: 1.530

7.  Hypochlorous acid causes caspase activation and apoptosis or growth arrest in human endothelial cells.

Authors:  M C Vissers; J M Pullar; M B Hampton
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

8.  Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection.

Authors:  K Morita; M Miura; D R Paolone; T M Engeman; A Kapoor; D G Remick; R L Fairchild
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

9.  Prolonged cold preservation augments vascular injury independent of renal transplant immunogenicity and function.

Authors:  D Dragun; U Hoff; J K Park; Y Qun; W Schneider; F C Luft; H Haller
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

10.  Apoptosis and chemokine induction after renal ischemia-reperfusion.

Authors:  M A Daemen; B de Vries; C van't Veer; T G Wolfs; W A Buurman
Journal:  Transplantation       Date:  2001-04-15       Impact factor: 4.939

View more
  25 in total

1.  Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine.

Authors:  Thomas Gobbetti; Nicolas Cenac; Jean-Paul Motta; Corinne Rolland; Laurence Martin; Patricia Andrade-Gordon; Martin Steinhoff; Elisabetta Barocelli; Nathalie Vergnolle
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

Review 2.  Neutrophil serine proteases fine-tune the inflammatory response.

Authors:  Christine T N Pham
Journal:  Int J Biochem Cell Biol       Date:  2007-11-29       Impact factor: 5.085

3.  High renal ischemia temperature increases neutrophil chemoattractant production and tissue injury during reperfusion without an identifiable role for CD4 T cells in the injury.

Authors:  Nobuyuki Fukuzawa; Austin D Schenk; Marianne Petro; Katsuya Nonomura; William M Baldwin; Robert L Fairchild
Journal:  Transpl Immunol       Date:  2009-08-05       Impact factor: 1.708

Review 4.  Mast cell peptidases: chameleons of innate immunity and host defense.

Authors:  Neil N Trivedi; George H Caughey
Journal:  Am J Respir Cell Mol Biol       Date:  2009-11-20       Impact factor: 6.914

Review 5.  Mediators of inflammation in acute kidney injury.

Authors:  Ali Akcay; Quocan Nguyen; Charles L Edelstein
Journal:  Mediators Inflamm       Date:  2010-02-21       Impact factor: 4.711

6.  Therapeutic landscape of carfilzomib and other modulators of the ubiquitin-proteasome pathway.

Authors:  Constantine S Mitsiades
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

7.  A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia.

Authors:  Mao Zhang; Pariya Sukhumalchandra; Atim A Enyenihi; Lisa S St John; Sally A Hunsucker; Elizabeth A Mittendorf; Anna Sergeeva; Kathryn Ruisaard; Zein Al-Atrache; Patricia A Ropp; Haroon Jakher; Tania Rodriguez-Cruz; Gregory Lizee; Karen Clise-Dwyer; Sijie Lu; Jeffrey J Molldrem; Gary L Glish; Paul M Armistead; Gheath Alatrash
Journal:  Clin Cancer Res       Date:  2012-11-12       Impact factor: 12.531

8.  Identification of Neutrophil Exocytosis Inhibitors (Nexinhibs), Small Molecule Inhibitors of Neutrophil Exocytosis and Inflammation: DRUGGABILITY OF THE SMALL GTPase Rab27a.

Authors:  Jennifer L Johnson; Mahalakshmi Ramadass; Jing He; Steven J Brown; Jinzhong Zhang; Lusine Abgaryan; Nikolaos Biris; Evripidis Gavathiotis; Hugh Rosen; Sergio D Catz
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

9.  Identification of agents that reduce renal hypoxia-reoxygenation injury using cell-based screening: purine nucleosides are alternative energy sources in LLC-PK1 cells during hypoxia.

Authors:  Petra Szoleczky; Katalin Módis; Nóra Nagy; Zoltán Dóri Tóth; Douglas DeWitt; Csaba Szabó; Domokos Gero
Journal:  Arch Biochem Biophys       Date:  2011-11-11       Impact factor: 4.013

Review 10.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.